Alyeska Investment Group, L.P. - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$898,000
-95.6%
37,583
-97.3%
0.01%
-95.8%
Q4 2020$20,453,000
-4.9%
1,400,918
-7.5%
0.29%
-11.6%
Q3 2020$21,507,000
+58.7%
1,514,598
+64.4%
0.33%
+59.5%
Q2 2020$13,549,000
+368.8%
921,050
+53.3%
0.20%
+439.5%
Q4 2019$2,890,000
-13.1%
600,932
+9.6%
0.04%
-20.8%
Q3 2019$3,324,000
+8.2%
548,442
+15.8%
0.05%
+20.0%
Q2 2019$3,073,000
-2.2%
473,442
+6.8%
0.04%
-4.8%
Q1 2019$3,142,000
-37.8%
443,142
-57.4%
0.04%
-43.2%
Q4 2018$5,054,000
+75.4%
1,040,000
+165.4%
0.07%
+131.2%
Q3 2018$2,881,000
-67.4%
391,909
-71.7%
0.03%
-59.5%
Q2 2018$8,829,000
+9.2%
1,383,828
-6.9%
0.08%
+17.9%
Q1 2018$8,087,000
+24.0%
1,486,490
-4.9%
0.07%
+28.8%
Q4 2017$6,521,000
-33.2%
1,563,881
+54.2%
0.05%
-28.8%
Q3 2017$9,764,000
+24.3%
1,013,881
+52.7%
0.07%
+10.6%
Q2 2017$7,856,000
+245.3%
664,062
+274.3%
0.07%
+266.7%
Q1 2017$2,275,000
+3.6%
177,435
-1.2%
0.02%0.0%
Q4 2016$2,197,000
-36.6%
179,523
-38.9%
0.02%
-43.8%
Q3 2016$3,467,000
+41.3%
293,813
+4.1%
0.03%
+39.1%
Q2 2016$2,454,000
+68.4%
282,123
+2.1%
0.02%
+76.9%
Q1 2016$1,457,000
-29.9%
276,398
+3.2%
0.01%
-40.9%
Q4 2015$2,079,000
-31.3%
267,854
-30.3%
0.02%
-38.9%
Q3 2015$3,025,000
-52.2%
384,332
-45.0%
0.04%
-2.7%
Q2 2015$6,326,000
+96.8%
698,306
+182.0%
0.04%
-17.8%
Q1 2015$3,214,000
-14.3%
247,587
-10.2%
0.04%
-29.7%
Q4 2014$3,752,000
+15.0%
275,706
-24.2%
0.06%
-4.5%
Q3 2014$3,262,000
-36.7%
363,695
-4.5%
0.07%
-41.2%
Q2 2014$5,154,000
+35.5%
380,896
-0.5%
0.11%
+9.6%
Q1 2014$3,804,000
+13.2%
382,724
+51.4%
0.10%
-21.8%
Q4 2013$3,361,000
-45.9%
252,868
-50.6%
0.13%
-47.6%
Q3 2013$6,209,000
+90.8%
511,474
+62.6%
0.25%
+58.8%
Q2 2013$3,254,000314,5020.16%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders